Accardi Mario Alberto (CIK 2074392) reported 19 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-24). Recent activity: Sell CNTA (243,282 shares), Sell CNTA (604 shares), Sell CNTA (2,915 shares), Buy CNTA (68,000 shares), Sell CNTA (7,432 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Sell | 243,282 | $0 |
| 2026-05-18 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Sell | 604 | $23,810 |
| 2026-02-03 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Sell | 2,915 | $71,622 |
| 2026-02-03 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Buy | 68,000 | $0 |
| 2025-12-09 | Centessa Pharmaceuticals plc (CNTA) | President, Orexin Program | Sell | 7,432 | $213,298 |
| 2025-12-09 | Centessa Pharmaceuticals plc (CNTA) | President, Orexin Program | Sell | 2,568 | $75,011 |
| 2025-12-08 | Centessa Pharmaceuticals plc (CNTA) | President, Orexin Program | Buy | 5,000 | $47,650 |
| 2025-12-08 | Centessa Pharmaceuticals plc (CNTA) | President, Orexin Program | Sell | 10,000 | $300,000 |
| 2025-11-03 | Centessa Pharmaceuticals plc (CNTA) | President, Orexin Program | Sell | 593 | $14,766 |
| 2025-10-27 | Centessa Pharmaceuticals plc (CNTA) | President, Orexin Program | Buy | 5,000 | $40,050 |
| 2025-10-27 | Centessa Pharmaceuticals plc (CNTA) | President, Orexin Program | Sell | 8,000 | $200,000 |
| 2025-09-16 | Centessa Pharmaceuticals plc (CNTA) | President, Orexin Program | Sell | 7,430 | $158,482 |
| 2025-09-16 | Centessa Pharmaceuticals plc (CNTA) | President, Orexin Program | Sell | 742 | $16,339 |
| 2025-09-11 | Centessa Pharmaceuticals plc (CNTA) | President, Orexin Program | Buy | 5,000 | $40,050 |
| 2025-09-11 | Centessa Pharmaceuticals plc (CNTA) | President, Orexin Program | Sell | 7,000 | $140,000 |
| 2025-08-01 | Centessa Pharmaceuticals plc (CNTA) | President, Orexin Program | Sell | 597 | $10,250 |
| 2025-07-30 | Centessa Pharmaceuticals plc (CNTA) | President, Orexin Program | Sell | 8,322 | $126,744 |
| 2025-06-25 | Centessa Pharmaceuticals plc (CNTA) | President, Orexin Program | Buy | 15,000 | $57,750 |
| 2025-06-25 | Centessa Pharmaceuticals plc (CNTA) | President, Orexin Program | Sell | 15,000 | $210,000 |
Source: SEC Form 4 filings · as of 2026-06-24